Report - FDA Briefing Document Committee Meeting February 09, · PDF fileAAC Brief BLA 125544 CT-P13, a proposed biosimilar to Remicade. FDA. Briefing Document Arthritis Advisory Committee

Please pass captcha verification before submit form